Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA ...

Retrieved on: 2022-03-19 16:34:48

Tags for this article:

Life Sciences

Medical specialties

RNA

COVID-19 vaccination in the United States

Clinical trials

Articles

Medical research

HIV vaccine development

MRNA vaccine

Moderna COVID-19 vaccine

HIV Vaccine Trials Network

Click the tags to see associated articles and topics

Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA .... View article details on HISWAI: https://pipelinereview.com/index.php/2022031980507/Vaccines/Moderna-Announces-First-Participant-Dosed-in-Phase-1-Study-of-its-HIV-Trimer-mRNA-Vaccine.html

Excerpt

CAMBRIDGE, Mam USA I March 14, 2022 I Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and ...

Article found on: pipelinereview.com

View Original Article